We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Abbott Diagnostics

Download Mobile App

Sekisui Diagnostics Showcases Clinical Chemistry and Immunoassay Analyzers

By LabMedica International staff writers
Posted on 31 Jul 2018
Print article
Image: The SK500 clinical chemistry system (Photo courtesy of Sekisui Diagnostics).
Image: The SK500 clinical chemistry system (Photo courtesy of Sekisui Diagnostics).
Sekisui Diagnostics (Lexington, MA, USA) showcased its clinical chemistry and immunoassay analyzers, including the SK500 clinical chemistry system and FastPack IP System, at the 70th Annual Scientific Meeting & Clinical Lab Expo held by the American Association for Clinical Chemistry (AACC) on July 29 – August 2, 2018 in Chicago, USA. AACC is the largest global scientific conference and tradeshow in laboratory medicine, with ~20,000 attendees and 750 exhibitors from around the world. AACC 2018 also provided Plenary Sessions featuring world-renowned scientists and scientific sessions covering a broad range of subjects at various experience levels, and focused “Brown Bag” sessions that gave attendees the opportunity to pose questions in small groups.

Sekisui Diagnostics provides diagnostic products in the areas of diabetes, infectious disease, coagulation, diagnostic enzymes and automated systems. The company’s product lines include clinical chemistry systems and reagents, coagulation systems and reagents, point of care rapid tests and immunoassay system, enzymes and specialty biochemical.

The SK500 Clinical Chemistry System showcased by Sekisui Diagnostics at AACC 2018 is a compact and efficient instrument with a full menu of high quality reagents specifically designed and packaged for the system, including the addition of a drugs of abuse testing menu. Sekisui Diagnostics also showcased the FastPack IP System, a fully automated quantitative immunoassay analyzer which uses sophisticated chemiluminescence technology to deliver accurate test results for commonly ordered tests in 12 minutes or less with a push of a button.

Also featured at the event was the company’s recently launched Silaris Influenza A&B Test which utilizes an affordable, polymerase chain reaction (PCR) testing platform specifically for point of care infectious disease diagnosis. It offers the simplicity, convenience and procedural familiarity of traditional visual read rapid tests, while providing the superior sensitivity and specificity of laboratory-based PCR testing.

Print article



view channel
Image: An enzyme-linked immunosorbent assay for mannose-binding lectin found that this molecule is associated with coagulopathy in severe COVID-19 patients (Photo courtesy of Getty Images).

Mannose-Binding Lectin Associated with Coagulopathy in Severe COVID-19

The ongoing COVID-19 pandemic has caused significant morbidity and mortality worldwide, as well as profound effects on society. COVID-19 patients have an increased risk of thromboembolic (TE) complications,... Read more

Industry News

view channel

2020 AACC Annual Scientific Meeting & Clinical Lab Expo to Be an All Virtual Event Due to Coronavirus Pandemic

The American Association for Clinical Chemistry (AACC Washington, DC, USA) has decided to hold the 2020 AACC Annual Scientific Meeting & Clinical Lab Expo as a virtual event, rather than as a live... Read more
Copyright © 2000-2020 Globetech Media. All rights reserved.